Random CPO related names I like: - $SIVE - Foci (3363) - $TSEM - Browave (3163) - PCL (4977) - $AXTI - Msscorps (6830) - $IQE - Shunsin (6451) - Furukawa Electric (5801) - $MTSI - Nextronics (8417) - $LITE - $COHR - FitTech (6706) - $GFS - $ASX - LandMark (3081) - $SOI Disclosure: I own most, not all though.

The May 29 "top 4 at current market caps" stock lis to BUY from the AI micro cap bottleneck guy against today's prices. $AAOI -63% $SIVE -75% Foci -45% to -52% Shunsin -54% $XFAB (runner-up) -54% The four main picks averaged roughly -60%. Three of them rallied another 28-60% in the first week after the post, then reversed. XFAB had already peaked two days before the post. Here's how the main claims hold up. AAOI was pitched at $12B on huge 2027 revenue. That 2027 number is a projection I can't verify. What I can verify is Q2 2026 revenue of $191.9M for the whole quarter, a $600M at-the-market share sale since the post, and a market cap now around $5B. SIVE was pitched at $2B on 77% pipeline growth and 60% gross margins. The pipeline growth is real. Q2 revenue was SEK 53.8M, down 12% year over year, and cost of revenue came in above revenue. The only covering analyst has a SEK 7.70 target. It trades at SEK 17.54. Foci was pitched at $2.8B as the FAU bottleneck for COUPE. Its own Q2 deck shows at least 4 FAU suppliers, silicon photonics/CPO at 9% of revenue, and a 0.2% gross margin. It's now about $1.5B. Shunsin was pitched at $2B as the hidden packaging play. The TSMC COUPE work is confirmed. It still ran a 16.8% gross margin in Q2 and traded around 334x earnings in October. It hit limit-down today. XFAB was pitched at ~$1.5B as an EU photonics champion. Autos are about two-thirds of revenue, photonics is still marginal, and volume photonics production is guided for 2028. The low price/book part is true at about 0.7x. It's now about $760M. The AI buildout can be real and these stocks can still be wrong. Bottleneck claims need checking against supplier counts, revenue mix and margins, not just the story. Prices are in local currency as of Nov 4, 2026. Shunsin and XFAB are late-session quotes. Foci's range reflects uncertainty about its May 29 starting price.

🚀 has completed multi-round financing totaling hundreds of millions RMB. Led by Ant Group, DiDi and Delian Capital, with participation from Shunwei, BV and Zelostech. Embodied AI needs more than models. It needs scalable Human Data infrastructure.

🎁Update Satisfaction Survey Winner Announcement We want to extend our heartfelt thanks to everyone who participated in our survey. We will select and announce 10 people from among those who carefully filled out the survey. [Winners] (10 users) JuicyWatermelo** Misak** ZealD** BrandOnToas** anonymous5** Colonel* Ral** Xaxa* ShinseiKout** Kiyo* Rewards have been distributed to everyone who participated in the survey, including the winners. Please check your mailbox now! 🎁 We will provide a separate notice with the satisfaction survey results in early September. Please stay tuned. Thank you.

$MRVL SVP and CTO of Optical Engineering Radha Nagarajan, at Semicon Taiwan: 1. Names Europe/Japan for laser supply sourcing as examples for SiPH modules. Very interesting that Marvell's SVP had Europe in mind when giving examples of laser supply sourcing for SiPH modules. I can't really name any notable public EU merchant laser suppliers other than $SIVE. Japan I can namedrop a few like Sumitomo/Furukawa etc. Maybe I'm reading too much into the geography, but a lot of US players like $LITE / $COHR / $AAOI are redirecting laser capacity internally, so it's interesting that the US wasn't mentioned. 2. Silicon photonics, high-speed drivers, amplifiers and DSPs come from other suppliers, with final integration taking place in Taiwan Makes sense, with $TSM COUPE / $ASX / ShunSin, and others. 3. Nagarajan appears to say NPO could arrive first around late 2027–2028, with full CPO continuing afterward. Good to hear more about commercialization timelines. $LITE similarly sees NPO around late 2027-H1 2028, while expecting CPO laser shipments in H2 2027 ahead of CPO scale up deployments in 2028. Revenue from upstream suppliers usually hits a bit earlier. 4. $MRVL on Google's TPU program vs. $AVGO / Mediatek and others. "Hyperscalers are seeking greater supply-chain diversification. If Google selects Marvell for a particular AI-chip segment, that does not mean it will stop working with MediaTek or Broadcom". Guess he's just trying to emphasize pie keeps growing for ASIC suppliers, nothing really too new. 5. All of Marvell's advanced ICs and ASICs are manufactured at TSMC, making the foundry central to the broader architecture. $TSM backbone of AI as usual. TLDR: - Very odd Marvell's SVP highlights Europe for laser sourcing, given how small a pool for merchant suppliers there is... - NPO volume looks late 2027, CPO after that. Upstream optical suppliers should start seeing revenue earlier

People wonder why I'm focusing on non-US markets recently. Why? CPO is my #1# thematic long. Markets don't know yet, the sudden paradigm shift in photonics... I was one of the only to frontrun the current supercycle in 2025 w/ $AAOI @ ~$30, $LITE ~$300s, and $AXTI at ~$13 on X.... With the actual receipts and thesis that others can't show. CPO goes from ~$0. To $91 Billion TAM opportunity. In the next 1 1/2 years from GS research. While overall optical market reaches $154B. Many players that had little exposure to the current photonics cycle at all: -> In Europe with high-end lasers design like $SIVE or $SOI with substrates. -> In Taiwan with Foci (3363), Nextronics (8147), Shunsin (6451) and others for optical components and foundries. -> In Japan with laser mass production, substrates, and chemicals. Are suddenly the new dominant players for CPO. As for US players, there's not much exposure. But the existing ones like $LITE, $COHR still get upside from CPO as that's their new growth vector. My contrarian thought process on current players: Is that most of their valuation is priced in huge legacy pluggable revenue that will inevitably face cannibalization over time, so re-rating potential is less unless someone uses leverage. A lot of these new purer play CPO names go from 0 to 100 extremely quickly one mass production starts H2 2026 for scale out (as a revenue bridge) into H2 2027 for scale up (massive growth driver). Markets usually price things in 8-12 months ahead of time too... I have high conviction thematically in my supply chain research despite any market volatility leading up until then.

Got curious and decided to track which thesis of mine were still up 100%+ YTD after the recent drawdown: 1. $AXTI - InP substrates 2. $NBIS - Neoclouds 3. $MU - Memory 4. $INTC - Foundry 5. $LITE - Photonics 6. $IQE - Epiwafers 7. $AAOI - Photonics 8. $GDRZF - Venezuela 9. $AEHR - Machines 10. $EWY (volatility + underlying) 11. $RPI - AI orchestration 12. $SOI - SIlicon Photonics Substrates 13. $SNDK - Memory 14. $SIMO - Memory 15. $MRVL - ASICs 16. Nanya - memory 17. Unimicron - substrates 18. $ARM - CPUs 19. $SIVE - Photonics From H1 2026, around 19 names across several themes up 100%+ still from the selection of winners. Since many like $TSEM / $HPS.A / $LPK / $ALRIB fell out of the range. (obviously not all are green like Shunsin / $XFAB and disappointed by performance). Regardless, glad a lot of my ideas turned out decently, rather than just being known for one like $AXTI. To the point the Chinese community gave my investing style a name "Perilla Leaf Theory". Again not too sure if my new ideas replicate this performance again in H2 2026 or 2027... For H2, my new thesis was on $CCXI for humanoids/downstream physical AI shift and ESMT for DDR2/DDR3/legacy memory. But I'll keep sharing my core ideas and thought process for free so people can poke holes or debate it until things get validated.